Pine Haven Investment Counsel’s iShares Biotechnology ETF IBB Stock Holding History

Pine Haven Investment Counsel’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,665	Closed	-$229K	–	112
2024 Q2	$229K	Hold	1,665	–	–	0.2%	95
2024 Q1	$228K	Hold	1,665	–	–	0.2%	96
2023 Q4	$226K	Hold	1,665	–	–	0.21%	94
2023 Q3	$204K	Hold	1,665	–	–	0.21%	96
2023 Q2	$211K	Hold	1,665	–	–	0.21%	97
2023 Q1	$215K	Hold	1,665	–	–	0.23%	97
2022 Q4	$219K	Buy	+1,665	New	+$215K	0.24%	96
2022 Q2	–	Sell	-1,665	Closed	-$217K	–	98
2022 Q1	$217K	Hold	1,665	–	–	0.21%	101
2021 Q4	$254K	Buy	+1,665	New	+$258K	0.24%	96

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Pine Haven Investment Counsel's IBB Position: Q3 2024 in Review

Pine Haven Investment Counsel sold out of iShares Biotechnology ETF (IBB) in Q3 2024, closing a stake of 1,665 shares — an estimated $229K sold.

Pine Haven Investment Counsel first reported a position in IBB in Q4 2021 and held it in 9 quarters. The position peaked at $254K in Q4 2021. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

Pine Haven Investment Counsel reported no remaining iShares Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
Pine Haven Investment Counsel sold 1,665 iShares Biotechnology ETF shares in Q3 2024, an estimated $229K.
Pine Haven Investment Counsel first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 9 quarters.
Pine Haven Investment Counsel's iShares Biotechnology ETF position peaked at $254K in Q4 2021.
893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on Pine Haven Investment Counsel's 13F filing for Q3 2024, filed 9 Oct 2024.